ACHIEVE LIFE SCIENCES, INC. (31) | Uncategorized (5)

Recent Contracts

Letter of Variation, dated September 28, 2020, by and between Achieve Pharma UK Limited and Richard Stewart (Filed With SEC on November 12, 2020)
Letter of Variation, dated September 28, 2020, by and between Achieve Pharma UK Limited and Anthony Clarke (Filed With SEC on November 12, 2020)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 13, 2020)
Form of Leak-out Agreement (Filed With SEC on December 16, 2019)
At The Market Offering Agreement, dated June 7, 2019, by and between Achieve Life Sciences, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 7, 2019)